CBD continues to flourish in the markets despite lack of federal
regulations, and we've identified some significant events that
indicate there's no sign it's stopping.
Topical CBD Pain-Relief Receives FDA Product Listing
Certification
Elixicure, an over-the-counter (OTC) CBD-infused topical
pain-relief cream marketed for treating inflammation, aches, and
pains, has received product listing certification from the Food
& Drug Administration (FDA). This certification is the first of
its kind for a topical OTC drug containing CBD. As Elixicure's
Chief of Business Development, Yaniv Kotler, explained,
"[t]his certification requires us to vet our processes, our
equipment and systems, our vendors and suppliers, and conduct
batch-by-batch testing to ensure quality."
